The patient’s family alleges that three Remdesivir vials were sold off by the hospital authorities. (File photo| Vinay Madapu, EPS) 
Hyderabad

Deceased Covid patient’s kin file complaint against Hyderabad's Rise Hospital

After the patient's death in June, his family members verified the hospital records and found that the drugs were not given properly and he was not on ventilator support.

Express News Service

HYDERABAD: A case has been registered against Rise Hospital at Vanasthalipuram, after a Covid patient undergoing treatment at the hospital, died due to alleged negligence of the hospital staff. The 42-year-old patient, a resident of Kothapet, was admitted to Rise Hospital in the last week of April, 2021, after he tested positive for Covid-19. His family had arranged six vials of Remdesivir as sought by the hospital. However, the family alleges that doctors used only three and told them that the patient was recovering.

Doctors also tried plasma therapy on the patient. Then, the hospital authorities informed the family that his condition had worsened and he was put on ventilator support. After his death in June, his family members verified the hospital records and found that the drugs were not given properly and he was not on ventilator support.

The patient’s family alleges that three Remdesivir vials were sold off by the hospital authorities. They lodged a complaint with the police three days ago. Meerpet Inspector M Mahender Reddy said a case had been registered against the hospital, police personnel are verifying the hospital records and collecting evidence.

Trump signs charter of 'Board of Peace' at Davos, says it will work 'in conjunction' with UN

T20 World Cup: BCB stands ground on not travelling to India after ICC ultimatum, says 'still hopeful'

Maoist leader with Rs 1 crore bounty among 15 killed in police encounter in Jharkhand's Saranda forests

'Treated like a dog': Flyer alleges harassment by Air India crew for demanding pre-booked meal to be served

India seeks $300–350 billion clean energy investment at World Economic Forum 2026

SCROLL FOR NEXT